Abolfazl Khoshdel1, Reza Imani Rastabi2, Abbas Doosti3, Shahin Askari4, Masoud Hafizi2. 1. Pediatrics Infectious Diseases Specialist, Department of Pediatrics, Shahrekord University of Medical Sciences , Shahrekord, Iran . 2. Infectious & Tropical Diseases Specialist, Department of Infectious & Tropical Diseases, Faculty of Medicine, Shahrekord University of Medical Sciences , Shahrekord, Iran . 3. Molecular Genetic Ph.D, Biotechnology Research Centre, Islamic Azad University , Shahrekord Branch, Shahrekord, Iran . 4. General Practitioner, Department of Internal Medicine, Shahrekord University of Medical Sciences , Shahrekord, Iran .
Abstract
BACKGROUND: Heptavalent pneumococcal vaccine which included pneumococcal serotypes 4, 6B, 9V,14, 18C, 19F and 23F has been regularly used and is effective on preventing invasive pneumococcal infection. This study aimed to determine vaccine-related serotype distribution in nasopharyngeal carrier and healthy children under five years old. MATERIALS AND METHODS: In this cross-sectional study from September 2010 to September 2011, 363 nasopharyngeal specimens were collected from healthy children in day care centers. In positive cultures of streptococcus pneumoniae (S. pneumonia) distribution, serotypes were detected by Multiplex polymerase chain reaction (PCR). Electrophoresis of PCR products was used for detection of serotypes of S. pneumoniae. RESULTS: The carrier rate of S. pneumoniae was 29.5% with 95% confidence interval as 24.8- 34.5%. Electrophoresis of PCR products for detection of serotypes of S. pneumonia revealed 430, 220, 753, 189, 573, 304, and 384 bp (s) for 4, 6B, 9V, 14, 18C, 19F, and 23F serotypes of S. pneumoniae, respectively. The frequency of 23F, 6B, 19F, and 18C serotypes were 43%, 34%, 18%, and 5% respectively, but other serotypes (4, 9V and 14) were not detected. CONCLUSION: Based on the 30% carrier rate and high prevalence of most of heptavalent pneumococcal conjugate vaccine serotypes in our study, this vaccine should be used for prevention of invasive infection in Iranian children.
BACKGROUND:Heptavalent pneumococcal vaccine which included pneumococcal serotypes 4, 6B, 9V,14, 18C, 19F and 23F has been regularly used and is effective on preventing invasive pneumococcal infection. This study aimed to determine vaccine-related serotype distribution in nasopharyngeal carrier and healthy children under five years old. MATERIALS AND METHODS: In this cross-sectional study from September 2010 to September 2011, 363 nasopharyngeal specimens were collected from healthy children in day care centers. In positive cultures of streptococcus pneumoniae (S. pneumonia) distribution, serotypes were detected by Multiplex polymerase chain reaction (PCR). Electrophoresis of PCR products was used for detection of serotypes of S. pneumoniae. RESULTS: The carrier rate of S. pneumoniae was 29.5% with 95% confidence interval as 24.8- 34.5%. Electrophoresis of PCR products for detection of serotypes of S. pneumonia revealed 430, 220, 753, 189, 573, 304, and 384 bp (s) for 4, 6B, 9V, 14, 18C, 19F, and 23F serotypes of S. pneumoniae, respectively. The frequency of 23F, 6B, 19F, and 18C serotypes were 43%, 34%, 18%, and 5% respectively, but other serotypes (4, 9V and 14) were not detected. CONCLUSION: Based on the 30% carrier rate and high prevalence of most of heptavalent pneumococcal conjugate vaccine serotypes in our study, this vaccine should be used for prevention of invasive infection in Iranian children.
Authors: Mark van der Linden; Susanne Weiß; Gerhard Falkenhorst; Annette Siedler; Matthias Imöhl; Rüdiger von Kries Journal: Vaccine Date: 2012-07-04 Impact factor: 3.641
Authors: Barbara E Mahon; Katherine Hsu; Sudharani Karumuri; Sheldon L Kaplan; Edward O Mason; Stephen I Pelton Journal: Vaccine Date: 2005-12-27 Impact factor: 3.641
Authors: Carrie L Byington; Matthew H Samore; Gregory J Stoddard; Steve Barlow; Judy Daly; Kent Korgenski; Sean Firth; David Glover; Jasmin Jensen; Edward O Mason; Cheryl K Shutt; Andrew T Pavia Journal: Clin Infect Dis Date: 2005-05-26 Impact factor: 9.079
Authors: Hope L Johnson; Maria Deloria-Knoll; Orin S Levine; Sonia K Stoszek; Laura Freimanis Hance; Richard Reithinger; Larry R Muenz; Katherine L O'Brien Journal: PLoS Med Date: 2010-10-05 Impact factor: 11.069
Authors: Simo M Granat; Zakaria Mia; Jukka Ollgren; Elja Herva; Milan Das; Liisa Piirainen; Kari Auranen; P Helena Mäkelä Journal: Pediatr Infect Dis J Date: 2007-04 Impact factor: 2.129